mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.003 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.003 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.003 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.003 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.004 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.004 |
mRNA |
GW843682X |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.004 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.005 |